Results 191 to 200 of about 3,384 (210)

Rasburicase

Paediatric Drugs, 2001
Rasburicase (recombinant urate oxidase) is a uricolytic agent which has been developed for the prevention and treatment of chemotherapy-induced hyperuricaemia at a dosage of 0.15 or 0.2 mg/kg/day in patients with haematological malignancies. Significant reductions from baseline in plasma uric acid levels were seen in 3 noncomparative and 1 randomised ...
J, Easton, S, Noble, B, Jarvis
  +5 more sources

Rasburicase

Reactions Weekly, 2022
openaire   +2 more sources

Rasburicase

Reactions Weekly, 2011
  +4 more sources

Home - About - Disclaimer - Privacy